Pharmaceutical Executive
By Pharmaceutical Executive Podcast
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Pharmaceutical Executive Podcast
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 5
Reviews: 0
Episodes: 348
Description
The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.
| Episode | Date |
|---|---|
|
Pharmaceutical Executive Daily: BioNTech Reports 2026 First Quarter Results
|
May 05, 2026 |
|
Pharmaceutical Executive Daily: UCB to Acquire Candid Therapeutics
|
May 04, 2026 |
|
Pharmaceutical Executive Daily: FDA Approves Auvelity
|
May 01, 2026 |
|
Pharmaceutical Executive Daily: Sanofi Appoints Belén Garijo as CEO
|
Apr 30, 2026 |
|
Pharmaceutical Executive Daily: Rocket Pharmaceuticals Sells Pediatric Disease Priority Review Voucher
|
Apr 29, 2026 |
|
Pharmaceutical Executive Daily: FDA Approves Breztri
|
Apr 28, 2026 |
|
Pharmaceutical Executive Daily: FDA Approves Caplyta for Adults with Schizophrenia
|
Apr 27, 2026 |
|
Pharmaceutical Executive Daily: FDA Issues CRL to AbbVie
|
Apr 24, 2026 |
|
Pharmaceutical Executive Daily: FDA Expands Approvals for Tzield and Dupixent
|
Apr 23, 2026 |
|
The Ron Lanton Report: Where Innovations Happens
|
Apr 23, 2026 |
|
Pharmaceutical Executive Daily: Idvynso Receives FDA Approval
|
Apr 22, 2026 |
|
Pharmaceutical Executive Daily: UnitedHealth Raises Full-Year Profit Forecast
|
Apr 21, 2026 |
|
Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics
|
Apr 20, 2026 |
|
Inside Pharma's Revenue Engine: The Gross-to-Net Reckoning
|
Apr 17, 2026 |
|
Pharmaceutical Executive Daily: Eli Lilly Releases Updated Safety Data for Foundayo
|
Apr 16, 2026 |
|
Pharmaceutical Executive Daily: Obsidian and Galera Therapeutics Enter Merger Agreement
|
Apr 15, 2026 |
|
Pharmaceutical Executive Daily: AbbVie and Haisco Enter $745 Million Licensing Agreement
|
Apr 14, 2026 |
|
Pharmaceutical Executive Daily: FDA Issues Second CRL for Replimune's RP1 Melanoma Treatment
|
Apr 13, 2026 |
|
Pharmaceutical Executive Daily: China Approves Amgen's Tarlatamab for Previously Treated Extensive-Stage Small Cell Lung Cancer
|
Apr 10, 2026 |
|
Why Branding is Pharma’s Most Undervalued Asset
|
Apr 10, 2026 |
|
Pharmaceutical Executive Daily: Shionogi Receives a Contract Through BARDA's Project BioShield
|
Apr 09, 2026 |
|
Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees
|
Apr 08, 2026 |
|
Pharmaceutical Executive Daily: Wegovy HD Now Available in the U.S.
|
Apr 07, 2026 |
|
Pharmaceutical Executive Daily: Neurocrine Biosciences Agrees to Acquire Soleno Therapeutics
|
Apr 06, 2026 |
|
Pharmaceutical Executive Daily: President Trump Imposes 100% Tariff for Branded Pharmaceuticals
|
Apr 03, 2026 |
|
Pharmaceutical Executive Daily: Leadership Turnover Under Trump Administration
|
Apr 02, 2026 |
|
Pharmaceutical Executive Daily: Trump Administration Delays Appeal of Federal Ruling Blocking Vaccine Policy Overhaul
|
Apr 01, 2026 |
|
Pharmaceutical Executive Daily: Novo Nordisk's Wegovy Subscription Program
|
Mar 31, 2026 |
|
Pharmaceutical Executive Daily: Eli Lilly Presses U.K. Government to Raise NHS Drug Pricing
|
Mar 30, 2026 |
|
Pharmaceutical Executive Daily: Novartis Acquires Excellergy Inc.
|
Mar 27, 2026 |
|
Pharmaceutical Executive Daily: Trump Administration Misses Deadline to Nominate Permanent CDC Director
|
Mar 26, 2026 |
|
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
|
Mar 25, 2026 |
|
Pharmaceutical Executive Daily: Bayer Shares Drop After Inclusive Capital Offloads Remaining Stake
|
Mar 24, 2026 |
|
Pharmaceutical Executive Daily: Pfizer Warns Shareholders to Reject Mini-Tender Offer
|
Mar 23, 2026 |
|
Pharmaceutical Executive Daily: FDA Approves Wegovy HD
|
Mar 20, 2026 |
|
The Ron Lanton Report: When Policy Becomes a Capital Event
|
Mar 20, 2026 |
|
Pharmaceutical Executive Daily: Analysis on TrumpRx List Pricing
|
Mar 19, 2026 |
|
Pharmaceutical Executive Daily: Federal Judge Halts Vaccine Advisory Council Appointments
|
Mar 18, 2026 |
|
Pharmaceutical Executive Daily: Conflict in Middle East Disrupts Pharma Supply Chains
|
Mar 16, 2026 |
|
Pharmaceutical Executive Daily: FDA Expands Approval for Arexvy
|
Mar 13, 2026 |
|
Pharmaceutical Executive Daily: Senate Democrats Seeking Information on MFN Pharma Deals
|
Mar 12, 2026 |
|
Moving CAR-T Beyond Oncology
|
Mar 11, 2026 |
|
Pharmaceutical Executive Daily: FDA's New Guidance for Biosimilar Development
|
Mar 11, 2026 |
|
Pharmaceutical Executive Daily: FDA Expands Approval of Leucovorin
|
Mar 10, 2026 |
|
Pharmaceutical Executive Daily: Vinay Prasad Set to Leave CBER for Second Time
|
Mar 09, 2026 |
|
Pharmaceutical Executive Daily: Cognito Therapeutics and Nexcure Secure Financing Rounds
|
Mar 05, 2026 |
|
Pharmaceutical Executive Daily: Pharma Industry's AI Adoption
|
Mar 04, 2026 |
|
The Ongoing Impact of MFN Pricing
|
Mar 04, 2026 |
|
Pharmaceutical Executive Daily: Novo Nordisk Commits $506 Million to Ireland Manufacturing Site
|
Mar 03, 2026 |
|
Pharmaceutical Executive Daily: FDA Approves Palynziq and Sogroya
|
Mar 02, 2026 |
|
Pharmaceutical Executive Daily: FDA Approves Hernexeos
|
Feb 27, 2026 |
|
Pharmaceutical Executive Daily: Alkermes' CEO Succession Plan
|
Feb 26, 2026 |
|
The Ron Lanton Report: Is Healthcare Consolidation Reaching Its Limits?
|
Feb 26, 2026 |
|
Pharmaceutical Executive Daily: FDA Approves Braftovi
|
Feb 25, 2026 |
|
Pharmaceutical Executive Daily: Novo Nordisk Announces Price Reductions for GLP-1 Products
|
Feb 24, 2026 |
|
Pharmaceutical Executive Daily: BioNTech Files Patent iInfringement Lawsuit Against Moderna
|
Feb 20, 2026 |
|
Pharmaceutical Executive Daily: FDA Plans to Remove Two Study Requirement for New Drug Approvals
|
Feb 19, 2026 |
|
Pharmaceutical Executive Daily: FDA Initiates Review of Moderna’s Seasonal Influenza Vaccine
|
Feb 18, 2026 |
|
Pharmaceutical Executive Daily: FDA Approves New Dosing Schedule for Rybrevant Faspro
|
Feb 17, 2026 |
|
Pharmaceutical Executive Daily: Disc Medicine Receives CRL from FDA for Bitopertin
|
Feb 16, 2026 |
|
Pharmaceutical Executive Daily: Eli Lilly's $1.5 Billion Stockpile of Orforglipron
|
Feb 13, 2026 |
|
Pharmaceutical Executive Daily: FDA Issues Refusal-to-File Letter to Moderna
|
Feb 11, 2026 |
|
Pharmaceutical Executive Daily: Specialized Wealth Management for BioPharmaceutical Sales
|
Feb 10, 2026 |
|
Bets and Balances: Riding the Risk-and-Innovation Pendulum in Biotech
|
Feb 10, 2026 |
|
Pharmaceutical Executive Daily: Hims & Hers Removes Access to New Compounded Semaglutide Pill
|
Feb 09, 2026 |
|
Pharmaceutical Executive Daily: The Launch of TrumpRx
|
Feb 06, 2026 |
|
Pharmaceutical Executive Daily: FDA Approves First and Only Oral Film Treatment for Erectile Dysfunction
|
Feb 05, 2026 |
|
Pharmaceutical Executive Daily: Susan G. Komen Releases Breast Cancer Outlook for 2026
|
Feb 04, 2026 |
|
Pharmaceutical Executive Daily: SanegeneBio's $1.5 Billion License Agreement with Genentech
|
Feb 03, 2026 |
|
Pharmaceutical Executive Daily: FDA Reveals PreCheck Pilot Program
|
Feb 02, 2026 |
|
Pharmaceutical Executive Daily: Public Citizen Sues The Trump Administration Over Undisclosed Drug Price Agreements
|
Jan 30, 2026 |
|
Pharmaceutical Executive Daily: The Disconnect Between Pharma and MedTech
|
Jan 29, 2026 |
|
Pharmaceutical Executive Daily: Eli Lilly Enters $1 Billion Research Collaboration with Seamless Therapeutics
|
Jan 28, 2026 |
|
Pharmaceutical Executive Daily: Roche Reports Positive Phase II Study Results for Dual GLP-1/GIP Receptor Agonist
|
Jan 27, 2026 |
|
Pharmaceutical Executive Daily: Mirum Pharmaceuticals Acquires Bluejay Therapeutics
|
Jan 26, 2026 |
|
Pharmaceutical Executive Daily: Tariff Uncertainty Accelerates Manufacturing Shifts
|
Jan 23, 2026 |
|
Pharmaceutical Executive Daily: United States' Set to Exit WHO
|
Jan 22, 2026 |
|
Pharmaceutical Executive Daily: New Study Finds No Evidence Linking Tylenol Use to Autism Risk
|
Jan 21, 2026 |
|
Pharmaceutical Executive Daily: GSK's $2 Billion Acquisition of RAPT Therapeutics
|
Jan 20, 2026 |
|
Pharmaceutical Executive Daily: Henlius' Exclusive License Agreement with U-Mab Biopharma
|
Jan 19, 2026 |
|
Pharmaceutical Executive Daily: President Trump's Great Healthcare Plan
|
Jan 16, 2026 |
|
Pharmaceutical Executive Daily: Continued Coverage of the 2026 J.P. Morgan Healthcare Conference
|
Jan 15, 2026 |
|
Pharmaceutical Executive Daily: 2026 J.P. Morgan Healthcare Conference Coverage
|
Jan 14, 2026 |
|
Pharmaceutical Executive Daily: Johnson & Johnson Continues $55 Billion Manufacturing Investment
|
Jan 12, 2026 |
|
Pharmaceutical Executive Daily: FDA Limits Regulations of Non-Medical Fitness Devices
|
Jan 08, 2026 |
|
Pharmaceutical Executive Daily: Amgen Acquires Dark Blue Therapeutics for $840 Million
|
Jan 07, 2026 |
|
Pharmaceutical Executive Daily: Alnylam Invests $250 Million in Manufacturing Facility
|
Jan 06, 2026 |
|
Pharmaceutical Executive Daily: Wegovy Pill Becomes Available
|
Jan 05, 2026 |
|
Pharmaceutical Executive Daily: FDA Approves Wegovy Pill
|
Dec 23, 2025 |
|
Pharmaceutical Executive Daily: Nine New Additions to TrumpRx
|
Dec 22, 2025 |
|
Scaling Sustainability: A Big Pharma Formula
|
Dec 22, 2025 |
|
Pharmaceutical Executive Daily: US Senate Passes Biosecure Act
|
Dec 19, 2025 |
|
Pharmaceutical Executive Daily: Pfizer's Stock Drops Following 2026 Revenue Projections Release
|
Dec 18, 2025 |
|
Pharmaceutical Executive Daily: FDA's Approval of Lerochol
|
Dec 17, 2025 |
|
Pharmaceutical Executive Daily: TrumpRx's Critical Blind Spot
|
Dec 16, 2025 |
|
Pharmaceutical Executive Daily: Retatrutide's Positive Phase III Trial Results
|
Dec 15, 2025 |
|
Pharmaceutical Executive Daily: FDA's Approval of Waskyra
|
Dec 11, 2025 |
|
Pharmaceutical Executive Daily: FDA's New Standard for CAR-T Approvals
|
Dec 10, 2025 |
|
Pharmaceutical Executive Daily: Carvykti Demonstrates Sustained Remissions
|
Dec 09, 2025 |
|
Pharmaceutical Executive Daily: FDA Approves Breyanzi
|
Dec 08, 2025 |
|
Pharmaceutical Executive Daily: Mark Cuban's Push for Generic Drug Fee Waivers
|
Dec 05, 2025 |
|
Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER
|
Dec 04, 2025 |
|
Pharmaceutical Executive Daily: FDA's Agentic AI Deployment
|
Dec 03, 2025 |
|
Pharmaceutical Executive Daily: Lilly Reduces the Price of Zepbound
|
Dec 02, 2025 |
|
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
|
Dec 01, 2025 |
|
Pharmaceutical Executive Daily: Novartis Cuts 550 Jobs
|
Nov 26, 2025 |
|
Pharmaceutical Executive Daily: Moderna's $1.5 Billion Loan
|
Nov 25, 2025 |
|
Pharmaceutical Executive Daily: Tesaro and AnaptysBio's Legal Battle
|
Nov 24, 2025 |
|
Pharmaceutical Executive Daily: Novartis' North Carolina Manufacturing Hub
|
Nov 21, 2025 |
|
Pharmaceutical Executive Daily: Moderna's $140 Million Manufacturing Investment
|
Nov 20, 2025 |
|
Pharmaceutical Executive Daily: FDA's Approval of Epkinly
|
Nov 19, 2025 |
|
Pharmaceutical Executive Daily: Novo Nordisk's Leadership Restructure
|
Nov 18, 2025 |
|
Pharmaceutical Executive Daily: WeightWatchers Planning to Offer Wegovy Following Approval
|
Nov 13, 2025 |
|
Pharmaceutical Executive Daily: Dr. Richard Pazdur Appointed as Director CDER
|
Nov 13, 2025 |
|
Pharmaceutical Executive Daily: AstraZeneca Becomes UK's Largest Stock
|
Nov 12, 2025 |
|
Pharmaceutical Executive Daily: Wegovy Shows Potential to Treat MASH Patients
|
Nov 11, 2025 |
|
Raising Biomarker Awareness
|
Nov 10, 2025 |
|
Pharmaceutical Executive Daily: FDA Approves Darzalex Faspro
|
Nov 10, 2025 |
|
Pharmaceutical Executive Daily: Lilly and Novo Nordisk Bring GLP-1's to TrumpRX
|
Nov 07, 2025 |
|
Pharmaceutical Executive Daily: Novo Nordisk's Amended Acquisition Proposal
|
Nov 06, 2025 |
|
Pharmaceutical Executive Daily: Kimberly-Clark’s $48.7 Billion Acquisition of Kenvue
|
Nov 05, 2025 |
|
Pharmaceutical Executive Daily: Pfizer Files Lawsuits Against Metsera and Novo Nordisk
|
Nov 04, 2025 |
|
Pharmaceutical Executive Daily: George Tidmarsh Resigns from FDA
|
Nov 03, 2025 |
|
Pharmaceutical Executive Daily: Novo Nordisk's Unsolicited Acquisition Proposal
|
Oct 31, 2025 |
|
Pharmaceutical Executive Daily: Thermo Fisher's $8.8 Billion Acquisition of Clario Holdings
|
Oct 30, 2025 |
|
Pharmaceutical Executive Daily: Lilly and NVIDIA Create AI Supercomputer
|
Oct 29, 2025 |
|
Pharmaceutical Executive Daily: Organon CEO Kevin Ali Resigns
|
Oct 28, 2025 |
|
Pharmaceutical Executive Daily: New Research Suggests Ozempic May Reduce Biological Age
|
Oct 27, 2025 |
|
Pharmaceutical Executive Daily: TrumpRx's Implication on DTC Commercialization
|
Oct 24, 2025 |
|
Pharmaceutical Executive Daily: Novo Nordisk's Shares Fall After Board Shake-Up
|
Oct 23, 2025 |
|
Pharmaceutical Executive Daily: Novo Nordisk's Board Shake-Up
|
Oct 22, 2025 |
|
Pharmaceutical Executive Daily: Merck's $70 Billion Investment
|
Oct 21, 2025 |
|
Pharmaceutical Executive Daily: FDA's National Priority Voucher Program
|
Oct 20, 2025 |
|
Shifting Focus in Autoimmune Diseases
|
Oct 20, 2025 |
|
Pharmaceutical Executive Daily: EMD Serono’s Agreement with US Government
|
Oct 17, 2025 |
|
Pharmaceutical Executive Daily: Rethinking Workforce Development
|
Oct 16, 2025 |
|
Pharmaceutical Executive Daily: Johnson & Johnson Separating Its Orthopedics Unit
|
Oct 15, 2025 |
|
Pharmaceutical Executive Daily: Direct-To-Consumer Trends
|
Oct 14, 2025 |
|
Advancing Neuroscience and Rare Disease Innovation
|
Oct 14, 2025 |
|
Pharmaceutical Executive Daily: Policy Whiplash
|
Oct 13, 2025 |
|
Pharmaceutical Executive Daily: Most Favored Nation Order's Evolving Landscape
|
Oct 10, 2025 |
|
Pharmaceutical Executive Daily: Why DSCSA Compliance is Only The Beginning
|
Oct 09, 2025 |
|
Pharmaceutical Executive Daily: Amgen Launches New Direct-To-Consumer Platform
|
Oct 08, 2025 |
|
Pharmaceutical Executive Daily: FDA Lifts Clinical Hold on NUZ-001
|
Oct 07, 2025 |
|
Pharmaceutical Executive Daily: Updated Vaccine Recommendations
|
Oct 06, 2025 |
|
Pharmaceutical Executive Daily: FDA's new Fast-Track Review
|
Oct 03, 2025 |
|
Pharmaceutical Executive Daily: President Trump Pauses Tariff Plan
|
Oct 02, 2025 |
|
Pharmaceutical Executive Daily: Novo Nordisk Resubmits BLA for Awiqli
|
Oct 01, 2025 |
|
Pharmaceutical Executive Daily: September 30, 2025
|
Sep 30, 2025 |
|
Pharmaceutical Executive Daily: September 29, 2025
|
Sep 29, 2025 |
|
Pharmaceutical Executive Daily: September 26, 2025
|
Sep 26, 2025 |
|
Pharmaceutical Executive Daily: September 25, 2025
|
Sep 25, 2025 |
|
Pharmaceutical Executive Daily: September 24, 2025
|
Sep 24, 2025 |
|
Pharmaceutical Executive Daily: September 23, 2025
|
Sep 23, 2025 |
|
Pharmaceutical Executive Daily: September 22, 2025
|
Sep 22, 2025 |
|
Pharmaceutical Executive Daily: September 19, 2025
|
Sep 19, 2025 |
|
Pharmaceutical Executive Daily: September 18, 2025
|
Sep 18, 2025 |
|
Pharmaceutical Executive Daily: September 17, 2025
|
Sep 17, 2025 |
|
Pharmaceutical Executive Daily: September 16, 2025
|
Sep 16, 2025 |
|
Pharmaceutical Executive Daily: September 15, 2025
|
Sep 15, 2025 |
|
Pharmaceutical Executive Daily: September 12, 2025
|
Sep 12, 2025 |
|
Pharmaceutical Executive Daily: September 11, 2025
|
Sep 11, 2025 |
|
Pharmaceutical Executive Daily: September 9, 2025
|
Sep 09, 2025 |
|
Pharmaceutical Executive Daily: September 8, 2025
|
Sep 08, 2025 |
|
Pharmaceutical Executive Daily: September 5, 2025
|
Sep 05, 2025 |
|
Pharmaceutical Executive Daily: September 4, 2025
|
Sep 04, 2025 |
|
Pharmaceutical Executive Daily: September 3, 2025
|
Sep 03, 2025 |
|
The Rx for High-Performance Leadership: Cutting Through the Chaos
|
Aug 22, 2025 |
|
Pharmaceutical Executive Weekly:CSL Cuts Jobs, Pfizer’s Sickle Cell Setback, and Eli Lilly Expands Zepbound Access
|
Aug 21, 2025 |
|
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
|
Apr 14, 2025 |
|
Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals
|
Mar 24, 2025 |
|
The Misinformation Maze: Navigating Public Health in the Digital Age
|
Mar 11, 2025 |
|
Navigating Distrust: Pharma in the Age of Social Media
|
Feb 18, 2025 |
|
Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement
|
Feb 10, 2025 |
|
The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations
|
Jan 30, 2025 |
|
Key Findings of the NIAGARA and HIMALAYA Trials
|
Nov 08, 2024 |
|
Fake Weight Loss Drugs: Growing Threat to Consumer Health
|
Oct 25, 2024 |
|
A Different Approach to Dermatology Care
|
Sep 23, 2024 |
|
Beyond the Birthrate: The Societal Costs of Maternal Morality
|
Sep 06, 2024 |
|
Empty Shelves, Urgent Solutions
|
Aug 05, 2024 |
|
The Weight-Loss Gold Rush: Legal and Regulatory Implications
|
Jul 11, 2024 |
|
Healthcare Marketing Strategies for Reaching Diverse Audiences
|
May 14, 2024 |
|
A Decade in the Anti-Obesity Arena
|
Apr 30, 2024 |
|
Fierce Females in the Life Science Space
|
Mar 28, 2024 |
|
Gen-Z Influence on Pharma M&A
|
Mar 14, 2024 |
|
Recent Licensing Agreement Poised to Advance Company ADC
|
Jan 26, 2024 |
|
Cell and Gene Therapy Check-in 2024
|
Jan 18, 2024 |
|
Reshaping Pharmacovigilance in the age of AI
|
Jan 04, 2024 |
|
Patient Centric Diabetes Care
|
Dec 14, 2023 |
|
DCT Opportunities in Clinical Research
|
Oct 26, 2023 |
|
New FDA SaMD Guidance Will Bring Monumental Changes to Industry
|
Oct 12, 2023 |
|
Venture Creation Firm Reveals Strategies For Launching New Companies & Forming Collaborations
|
Sep 28, 2023 |
|
Avoiding Commercialization Pitfalls for CGTs
|
Sep 14, 2023 |
|
Ethical AI Practices
|
Aug 31, 2023 |
|
Drug Pricing Challenges and Navigating The IRA
|
Aug 17, 2023 |
|
Pharma Marketing in the Age of AI: A New Era Begins
|
Aug 03, 2023 |
|
Transforming Cancer Care: Data, AI, and Patient-Centered Care
|
Jul 20, 2023 |
|
AI Frontiers: Navigating the Risks, Rewards, and Regulations
|
Jul 06, 2023 |
|
Listening is the Key to Good Leadership
|
Jun 22, 2023 |
|
The Trust Imperative: Defining and Building Trust in Pharma
|
Jun 08, 2023 |
|
Emerging Potential: Changing Lives One Story, One Therapeutic at a Time
|
May 25, 2023 |
|
Drug Approvals And Launches From A Legal Perspective
|
May 11, 2023 |
|
Exploring Arcutis’s Patient - Centric Dermatology Innovations
|
Apr 27, 2023 |
|
Tackling Reproductive Health And Fertility Care
|
Apr 13, 2023 |
|
Repurposing Drugs - How One Doctor Saved His Own Life And Hopes To Save Others
|
Mar 30, 2023 |
|
Tearing Down Silos to Usher Innovative Medicines to Patients Faster
|
Mar 16, 2023 |
|
Recruiting Talent In Pharma
|
Mar 02, 2023 |
|
Behind the Creative: Let’s Hear from the Creators
|
Feb 27, 2023 |
|
The Explosive Arrival of Chat GPT and Generative AI
|
Feb 16, 2023 |
|
Working In A Male-Dominated Field
|
Feb 02, 2023 |
|
Let’s Get Social: The Ascendancy of Social Media to the Top of the Media Mix
|
Jan 19, 2023 |
|
Gene Therapies: 2023 Predictions and Commercialization Challenges
|
Jan 05, 2023 |
|
In Flux: The Sales & Marketing Outlook For 2023
|
Dec 22, 2022 |
|
The Gap In Mental Health Treatments: Schizophrenia
|
Dec 08, 2022 |
|
Tuning Into CTV - Real Time Data For Marketers
|
Nov 24, 2022 |
|
Leadership in the US vs. Europe and Launching a Rare Disease Drug
|
Nov 10, 2022 |
|
Sounds of Our Sister Brands
|
Oct 27, 2022 |
|
Behind the Creative…..Inspiring Award Winning Creative with Sarah McKinnon
|
Oct 26, 2022 |
|
Making a Difference
|
Oct 13, 2022 |
|
Derm Decisions For Younger Children
|
Sep 29, 2022 |
|
From Persia To Precision Medicine
|
Sep 15, 2022 |
|
The Quest To Counter Alzheimer’s
|
Sep 01, 2022 |
|
Defining Diversity
|
Aug 18, 2022 |
|
Behind the Creative….Inspiring Award Winning Creative with Halen Dang and Carrie Morris
|
Aug 09, 2022 |
|
Managing Workplace Stress
|
Aug 04, 2022 |
|
Serving The Patient
|
Jul 21, 2022 |
|
Behind the Creative…Inspiring Award Winning Creative Carolyn O’Neill
|
Jul 19, 2022 |
|
Emerging Successful
|
Jul 07, 2022 |
|
Behind the Creative…Inspiring Award Winning Creative with Omair Ahmed
|
Jun 29, 2022 |
|
Creating A Space For Women’s Health
|
Jun 23, 2022 |
|
Inside The Metaverse For Pharma
|
Jun 09, 2022 |
|
Behind the Creative…Inspiring Award Winning Creative with John England
|
Jun 08, 2022 |
|
New Guidance For Biopharma Investor ESG Communications
|
May 26, 2022 |
|
Behind the Creative...Inspiring Award Winning Creative with Cindy Machles and Nate Whipple
|
May 25, 2022 |
|
Announcing Our 2022 Emerging Pharma Leaders
|
May 12, 2022 |
|
Behind the Creative...Inspiring Award Winning Creative with Troy Clark and Anne Brown
|
May 11, 2022 |
|
The Pulse Of Oncology
|
Apr 28, 2022 |
|
Changing Cancer Care with CAR-T
|
Apr 14, 2022 |
|
A Look at Latin America
|
Mar 31, 2022 |
|
The Art of Science
|
Mar 17, 2022 |
|
Respiratory Issues
|
Mar 03, 2022 |
|
Serving an Aging Population
|
Feb 17, 2022 |
|
Digital Awareness
|
Feb 03, 2022 |
|
Industry Outlook 2022
|
Jan 20, 2022 |
|
Episode 99: Caring About Specialty
|
Jan 06, 2022 |
|
Episode 98: Family Run Pharma
|
Dec 23, 2021 |
|
Episode 97: Diving Into Pharm Exec’s 2022 Pipeline Report
|
Dec 09, 2021 |
|
Episode 96: Forging New Paths In Oncology
|
Nov 25, 2021 |
|
Episode 95: CEOs Share Their Industry Outlook
|
Nov 11, 2021 |
|
Episode 94: Women Leading The Way
|
Oct 28, 2021 |
|
Episode 93: Cultural Cues in Oncology
|
Oct 14, 2021 |
|
Episode 92: Digesting The GI Market
|
Sep 30, 2021 |
|
Episode 91: A New Way to Partner With Academia
|
Sep 16, 2021 |
|
Episode 90: Innovating Ways to Fight Cancer
|
Sep 02, 2021 |
|
Episode 89: Cellicon Valley Outlook
|
Aug 19, 2021 |
|
Episode 88: The Science of Starting a Biotech
|
Aug 05, 2021 |
|
Episode 87: Attacking Bladder Cancer From All Sides
|
Jul 22, 2021 |
|
Behind the Creative...Inspiring Award Winning Creative with Cherie Davies
|
Jul 16, 2021 |
|
Episode 86: Cancer as a Catalyst
|
Jul 08, 2021 |
|
Episode 85: Managing the Dynamics of Oncology
|
Jun 24, 2021 |
|
Episode 84: Vaccines Beyond COVID
|
Jun 10, 2021 |
|
Behind the Creative...Inspiring Award Winning Creative with Kathy Delaney
|
Jun 10, 2021 |
|
Episode 83: The Strength of Veterans in Pharma
|
May 27, 2021 |
|
Behind the Creative: Creative Impact on Brand Success
|
May 25, 2021 |
|
Announcing Our 2021 Emerging Pharma Leaders
|
May 21, 2021 |
|
Episode 82: Integrating Sustainability Into Biopharma Strategy
|
May 13, 2021 |
|
Behind the Creative: Inspiring Award-Winning Creative
|
May 03, 2021 |
|
Episode 81: Cancer Research Amid COVID
|
Apr 29, 2021 |
|
Episode 80: Rugby Rules in Pharma
|
Apr 15, 2021 |
|
Episode 79: Managing Quarantine Remotely
|
Apr 01, 2021 |
|
Episode 78: The Digital Denouement of COVID
|
Mar 18, 2021 |
|
Episode 77: The Effects of AI on IP
|
Mar 04, 2021 |
|
Episode 76: Repatriating Pharma
|
Feb 18, 2021 |
|
Episode 75: Protecting Pharma Through Cybersecurity
|
Feb 04, 2021 |
|
Episode 74: 2021 Industry Outlook
|
Jan 21, 2021 |
|
Episode 73: Biotech’s IPO Steamroll
|
Jan 07, 2021 |
|
Episode 72: Trying to Outpace Rare Disease
|
Dec 24, 2020 |
|
Episode 71: Connecting With NPs and PAs
|
Dec 10, 2020 |
|
Episode 70: Keeping Pharma Informed
|
Nov 26, 2020 |
|
Episode 69: Fighting Influenza During COVID
|
Nov 12, 2020 |
|
Episode 68: Rocking Garage Biotech
|
Oct 29, 2020 |
|
Episode 67: Succeeding Through Adversity
|
Oct 15, 2020 |
|
Episode 66: New Approach to Antithrombotics
|
Oct 01, 2020 |
|
Episode 65: Creating a Path for Innovation
|
Sep 17, 2020 |
|
Episode 64: The Complexities of Managing ADHD
|
Sep 03, 2020 |
|
Episode 63: Three Simple Principles to Improve Leadership
|
Aug 20, 2020 |
|
Episode 62: The Future of Pharma’s Supply Chain
|
Aug 06, 2020 |
|
Episode 61: Preparing for Virtual High-Stakes Meetings
|
Jul 23, 2020 |
|
Episode 60: Leading With Compassion
|
Jul 09, 2020 |
|
Episode 59: Using Tau to Target Alzheimer’s
|
Jun 25, 2020 |
|
Episode 58: Understanding FDA’s Gene Therapy Guidelines
|
Jun 11, 2020 |
|
Episode 57: Planning for Pharma’s New Normal
|
May 28, 2020 |
|
Episode 56: Killing Cancer Through Direct Injection
|
May 14, 2020 |
|
Episode 55: Developing a Maternal RSV Vaccine
|
Apr 30, 2020 |
|
Episode 54: Taking Advantage of Digital Marketing
|
Apr 15, 2020 |
|
Episode 53: Fabulous Pharma Females
|
Apr 02, 2020 |
|
Episode 52: Cannabinoids
|
Mar 19, 2020 |
|
Episode 51: Combating Coronavirus
|
Mar 05, 2020 |
|
Episode 50: Pharma Pricing Climate in Washington
|
Feb 20, 2020 |
|
Episode 49: Navigate Emerging Markets with Data Science
|
Feb 06, 2020 |
|
Episode 48: 2020 Industry Outlook
|
Jan 23, 2020 |
|
Episode 47: Identifying Adherence Issues
|
Jan 09, 2020 |
|
Episode 46: Persistence and Planning Pays Off
|
Dec 19, 2019 |
|
Episode 45: Getting Drug Approval Through FDA LPAD
|
Dec 05, 2019 |
|
Episode 44: Annual Pipeline Report
|
Nov 21, 2019 |
|
Episode 43: Pharma Reputation
|
Nov 07, 2019 |
|
Episode 42: Establishing a New Drug Therapy
|
Oct 17, 2019 |
|
Episode 41: The Patient Journey
|
Oct 03, 2019 |
|
Episode 40: Global Pharma Outlook
|
Sep 19, 2019 |
|
Episode 39: CEO Builds Business With Compassion
|
Sep 05, 2019 |
|
Episode 38: Customer-Centric Innovation
|
Aug 22, 2019 |
|
Episode 37: Differentiating Yourself in Crowded Therapeutic Areas
|
Aug 08, 2019 |
|
Episode 36: A View from the Editors' Desks
|
Jul 25, 2019 |
|
Episode 35: Communicating Your Narrative with Healthcare Marketing
|
Jul 11, 2019 |
|
Episode 34: The Future of the Life Sciences Executive
|
Jun 21, 2019 |
|
Episode 33: Translationally Enabled Pharma
|
Jun 11, 2019 |
|
Episode 32: Change Your Behaviors, Change Your Health & Wellness
|
May 23, 2019 |
|
Episode 31: Ruling in Favor of Biotech
|
May 10, 2019 |
|
Episode 30: Challenges in Renal Disease Drug Development
|
Apr 25, 2019 |
|
Episode 29: Disease Prevention & Interception
|
Apr 11, 2019 |
|
Episode 28: Digital Medication
|
Mar 28, 2019 |
|
Episode 27: Sensitive Topics in Pharma
|
Mar 15, 2019 |
|
Episode 26: Patient Advocacy
|
Mar 01, 2019 |
|
Episode 25: China’s Pharma Growth
|
Feb 14, 2019 |
|
Episode 24: 2019 Industry Trends
|
Feb 05, 2019 |
|
Episode 23: Mindfulness in Clinical Trial R&D
|
Jan 17, 2019 |
|
Episode 22: Virtual Reality and Marketing in Healthcare
|
Dec 13, 2018 |
|
Episode 21: Southeast Biotech
|
Nov 29, 2018 |
|
Episode 20: Analyzing the Pharma Pipeline
|
Nov 08, 2018 |
|
Episode 19: How a CEO pivots Their Company and Career
|
Oct 25, 2018 |
|
Episode 18: Data’s Influence on the Pharma C-suite
|
Oct 11, 2018 |
|
Episode 17: Commercializing Research
|
Sep 27, 2018 |
|
Episode 16: Specialty Pharma
|
Sep 13, 2018 |
|
Episode 15: Impact of Robotics in Pharma
|
Aug 23, 2018 |
|
Episode 14: Emerging Biotech in NYC
|
Aug 02, 2018 |
|
Episode 13: How to Run a Successful Clinical-Stage Pharma Startup
|
Jul 19, 2018 |
|
Episode 12: Midwest Biotechs and Regenerative Medicine
|
Jul 06, 2018 |
|
Episode 11: From Field to Boardroom with Former NFL Star Solomon Wilcots
|
Jun 25, 2018 |
|
Episode 10: Mentoring and Sponsoring
|
Jun 07, 2018 |
|
Episode 9: 2018 PE Brands of the Year
|
May 24, 2018 |
|
Episode 8: CFO Insights From the Field
|
May 15, 2018 |
|
Episode 7: Big-Event Insights
|
Apr 26, 2018 |
|
Episode 6: The Pharma vs. Biotech Experience
|
Apr 12, 2018 |
|
Episode 5: Med Affairs Training
|
Mar 26, 2018 |
|
Episode 4: Outcomes-Based Contracting
|
Mar 16, 2018 |
|
Episode 3: Pharma's Reputation
|
Feb 23, 2018 |
|
Episode 2: JPMorgan Healthcare Conference 2018
|
Feb 12, 2018 |
|
Episode 1: 2018 Pharmaceutical Trends
|
Jan 23, 2018 |